Researchers discover potential treatment for sepsis and other responses to infection

Ebola and other dangerous microbes often produce these inflammatory responses. Researchers say that tiny doses of a cancer drug may stop the raging, uncontrollable immune response to infection that leads to sepsis and kills up to 500,000 people a year in the US. The new drug treatment may also benefit millions of people worldwide who are affected by infections and pandemics.